CTOs on the Move

Delta Regional Medical Center

www.deltaregional.com

 
Delta Regional Medical Center has been committed to serving the citizens of Washington County and the outlying areas since our founding in the 1950s. Over time we have grown and progressed into a state-of-the-art hospital with a number of specialty
  • Number of Employees: 5K-10K
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Legacy Press

Legacy Press is a Blackwood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lighthouse of Pinellas

Lighthouse of Pinellas is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Largo, FL. To find more information about Lighthouse of Pinellas, please visit www.lighthouseofpinellas.org

Evidation Health

Evidation Health is a technology and services company that helps individuals and the world`s most innovative healthcare companies understand and influence the everyday behaviors that create better health outcomes. Evidation pairs a first of its kind discovery engine designed for better, faster, and more efficient studies with a delivery platform that connects individuals and the healthcare industry, including life sciences organizations, providers, payers, and digital health companies. The company`s technology is designed to be entirely privacy-safe and individually-permissioned. Evidation Health`s mission is to enable and empower everyone to participate in better health outcomes. The company is headquartered in San Mateo, CA, with additional offices in Santa Barbara, CA.

TrustPoint Hospital

TrustPoint Hospital is an inpatient hospital that provides medical and psychiatric services for adults and seniors, with a focus on mental health and substance use disorder treatment.

Plasmatech Biopharmaceuticals

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.